SCHEMBL6168495

SCHEMBL6168495

CC(C(=O)O)c1c(C(=O)c2ccc(Cl)cc2)[nH]c2ccc(OC(F)(F)F)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.45
TRPV1 Q8NER1 2/20 0.44
PPARG P37231 8/20 0.44
PPARA Q07869 7/20 0.44
CYP2C9 P11712 3/20 0.44
EGFR P00533 1/20 0.44
CHRM4 P08173 1/20 0.44
ADRB1 P08588 1/20 0.44
ADRA2A P08913 1/20 0.44
ALOX5 P09917 1/20 0.44
ADRB3 P13945 1/20 0.44
DRD2 P14416 1/20 0.44
ADRA2B P18089 1/20 0.44
CHRM3 P20309 1/20 0.44
TACR2 P21452 1/20 0.44
DRD1 P21728 1/20 0.44
TBXA2R P21731 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
OPRM1 P35372 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173199 0.94 MAPT (0.47) MAPTTRPV1PPARGPPARACYP2C9
SCHEMBL6171552 0.88 PTGS2 (0.44) MAPTTRPV1PPARGPPARACYP2C9
SCHEMBL6172928 0.87 HPGD (0.47) MAPTPTGS2PTGS1MEN1ABCC4
SCHEMBL6172333 0.84 MEN1 (0.44) MAPTCYP2C9EGFRPTGS2PTGS1
SCHEMBL6170865 0.83 MAP2 (0.52) MAPTPTGS2PTGS1MEN1ABCC4
SCHEMBL6171246 0.82 PTGS2 (0.47) MAPTPTGS2PTGS1MEN1ABCC4
SCHEMBL6171881 0.81 KIF11 (0.46) MAPTPTGS2PTGS1MEN1ABCC4
SCHEMBL6173940 0.81 CNR1 (0.46) MAPTCYP2C9PTGS2PTGS1MEN1
SCHEMBL6171993 0.81 PTGS2 (0.52) MAPTPTGS2PTGS1MEN1ABCC4
SCHEMBL6171620 0.80 MAPT (0.47) MAPTTRPV1PTGS2PTGS1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP claimed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US claimed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed